Explore

How One Vitamin Went From Lab Breakthrough to Beauty Staple

How One Vitamin Went From Lab Breakthrough to Beauty Staple

Retinol, a form of vitamin A, has a rich history that spans over a century. From its discovery in the early 20th century to its widespread use in m...

After Gaza devastation, Israeli attacks on Lebanon's health care system feel familiar for many

After Gaza devastation, Israeli attacks on Lebanon's health care system feel familiar for many

Since the war between Israel and the militant group Hezbollah reignited on March 2, Israel has pushed deeper into southern Lebanon

Research Highlights Impact of Insurance on Cancer Survival Among Young Adults

Research Highlights Impact of Insurance on Cancer Survival Among Young Adults

Recent research underscores the significant role that insurance status plays in cancer survival rates among young adults in the United States. A comprehensive review of scientific literature, involving nearly 470,000 Americans aged 15 to 39 diagnosed with cancer, reveals that those with private health insurance have a survival advantage over those on Medicaid or without insurance. This advantage varies by cancer type, with private insurance reducing the risk of death by 8% for lymphoma and up to 2.5 times for melanoma and other cancers. The study highlights the instability of health coverage for young adults, who often lose insurance when they turn 26 or start jobs without benefits, leaving many uninsured or underinsured. This instability exacerbates the already slower improvements in cancer survival rates for this age group compared to children and older adults.

Bangladesh Faces Suspected Measles Outbreak, Affecting Thousands of Children

Bangladesh Faces Suspected Measles Outbreak, Affecting Thousands of Children

Bangladesh is currently dealing with a suspected measles outbreak that has reportedly resulted in the deaths of at least 98 children over the past three weeks. Official data indicates that the number of children aged between six months and five years showing symptoms of measles has surged to 6,476. The outbreak has prompted the government to intensify vaccination efforts, particularly in the most affected areas. Health officials have noted that the number of suspected cases is higher than in previous years, with a significant increase in both cases and fatalities. The outbreak is attributed to several factors, including a shortage of vaccines. Despite advancements in vaccination programs, a planned measles vaccination drive was delayed due to political unrest in 2024. The government is now focusing on vaccinating the worst-affected regions to curb the spread of the disease.

Researchers Identify Bemnifosbuvir as Potential Treatment for Hepatitis E

Researchers Identify Bemnifosbuvir as Potential Treatment for Hepatitis E

An international team of researchers has identified bemnifosbuvir, a drug currently in trials for hepatitis C, as a promising candidate for treating hepatitis E. The study, published in the journal Gut, involved scientists from Bochum and Heidelberg in Germany and Beijing in China. Bemnifosbuvir belongs to a class of molecules known as nucleotide/nucleoside analogues, which mimic the building blocks of genetic material. The researchers tested approximately 500 compounds using a specially engineered hepatitis E virus that produces a fluorescent signal. This method allowed them to determine whether the virus continued to replicate after treatment. The results showed that bemnifosbuvir effectively stopped the virus from replicating while keeping the treated cells healthy. Follow-up studies in animals confirmed the drug's ability to reduce viral activity and liver inflammation.

High-Dose Flu Vaccine Linked to Lower Alzheimer's Risk in Older Adults

High-Dose Flu Vaccine Linked to Lower Alzheimer's Risk in Older Adults

A recent study published in Neurology has found that receiving a high-dose flu vaccine is associated with a significantly lower risk of developing Alzheimer's disease in adults aged 65 and older. Conducted by researchers at the McGovern Medical School at UTHealth in Houston, the study analyzed health data from approximately 165,000 older adults who received either a high-dose or standard-dose influenza vaccine. The findings revealed that the high-dose flu vaccine reduced the risk of Alzheimer's by nearly 55% over a two-year period. This study builds on previous research by the same team, which found that the standard-dose vaccine was linked to a 40% reduced risk of Alzheimer's over four years. The high-dose vaccine contains four times the antigen of standard-dose vaccines, which is believed to enhance immune response and reduce inflammation, a factor thought to contribute to Alzheimer's development.

Study Reveals BMI Misclassification for Over One Third of Adults

Study Reveals BMI Misclassification for Over One Third of Adults

Recent research from Italy indicates that the body mass index (BMI) system may inaccurately classify many individuals regarding their weight status. The study, presented at the European Congress on Obesity and published in Nutrients, utilized dual-energy X-ray absorptiometry (DXA) to measure body fat, revealing discrepancies in BMI classifications. The research involved 1351 adults, showing that BMI often mislabels individuals as overweight or obese. The study found that among those classified as obese by BMI, 34% were actually overweight according to DXA results. Similarly, over half of those labeled overweight by BMI were misclassified, with many falling into the normal weight range. The findings suggest that BMI may overestimate the prevalence of overweight and obesity, prompting calls for updated public health guidelines.

World Food Safety Day 2026 Planning Webinar Announced by Global Agriculture

World Food Safety Day 2026 Planning Webinar Announced by Global Agriculture

Global Agriculture has announced a planning webinar for World Food Safety Day 2026, scheduled for April 7. The event will feature experts from the World Health Organization (WHO), the Food and Agriculture Organization (FAO), and the Codex Secretariat. The theme for this year is 'From burden to solutions – safe food everywhere,' focusing on the global burden of foodborne diseases. The webinar will discuss the upcoming release of the second edition of the FERG report, which provides updated estimates on foodborne illnesses and their impact.

US-Israeli Attacks Devastate Iran's Historic Pasteur Institute

US-Israeli Attacks Devastate Iran's Historic Pasteur Institute

The Pasteur Institute of Iran, a century-old medical facility in Tehran, has been severely damaged amid US and Israeli military actions. The World Health Organization (WHO) reported that the institute, crucial for public health services, is now unable to function. Established in 1920, the institute has been pivotal in producing vaccines and serums for diseases like smallpox and cholera. The attack is part of a broader pattern of assaults on Iran's healthcare infrastructure, with at least 20 incidents verified by the WHO since March 1. The destruction of the institute has sparked criticism, highlighting its role in Iran's healthcare system and its historical significance.

Subscription Pricing Model Proposed for HIV Prevention Drug Lenacapavir

Subscription Pricing Model Proposed for HIV Prevention Drug Lenacapavir

Subscription Pricing Model Proposed for HIV Prevention Drug Lenacapavir

South African Hospitals Conduct Marathon Eye Surgeries to Restore Sight

South African Hospitals Conduct Marathon Eye Surgeries to Restore Sight

In South Africa, a series of marathon cataract surgeries were conducted at two hospitals, restoring sight to 133 individuals. These surgeries were part of a public-private partnership initiative aimed at reducing the backlog of cataract operations in the country. Patients in South Africa's public health system often face long waiting times for cataract surgery, with some waiting since 2019. Cataracts, a common age-related condition, cause the eye's lens to become clouded, leading to curable blindness. The surgeries involved replacing the clouded lens with an artificial one, significantly improving the quality of life for patients like 84-year-old Gladys Khoza, who can now see her family and enjoy activities like reading and watching television.

Cures Within Reach Utilizes Small Grants to Advance Drug Repurposing Efforts

Cures Within Reach Utilizes Small Grants to Advance Drug Repurposing Efforts

Cures Within Reach, a Chicago-based nonprofit, is pioneering the use of small grants to support early-stage clinical trials for drug repurposing. This approach focuses on testing existing drugs for new therapeutic uses, which is faster and less costly than developing new drugs. Despite the potential benefits, large pharmaceutical companies often overlook these opportunities due to expired patents and limited commercial incentives. The nonprofit's model involves funding small proof-of-concept trials to generate initial data, which can then attract larger investments for further research. This strategy has been effective in bridging the 'valley of death'—the funding gap between promising lab results and human trials. Cures Within Reach has successfully leveraged its $12 million in grants to secure $145 million in follow-on investments, demonstrating the potential of small-scale funding to catalyze significant advancements in medical research.